Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GeneMatrix is a South Korean molecular diagnostics company focused on multiplex real-time PCR and related genotyping technologies for infectious disease testing and companion diagnostics. The company markets NeoPlex-branded in vitro diagnostic assays that support single-tube, multi-pathogen detection across sexually transmitted infections, respiratory infections, tuberculosis/nontuberculous mycobacteria, and HPV screening. GeneMatrix highlights proprietary platform technologies including C-Tag multiplex PCR, liquid bead microarray genotyping, and mass-spectrometry-based genotyping. It is a publicly listed company on KOSDAQ and appears to operate primarily as a commercial-stage diagnostics business rather than a therapeutics developer, although it has historically described broader diagnostics-and-therapeutics ambitions. Its customer base appears to be clinical laboratories and diagnostic professionals, with products emphasizing workflow efficiency, multiplexing, and rapid turnaround.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GeneMatrix.